慢性乙诗型病毒性肝炎治疗中的常见问题及解答.pptVIP

  • 2
  • 0
  • 约1.28万字
  • 约 50页
  • 2019-05-28 发布于福建
  • 举报

慢性乙诗型病毒性肝炎治疗中的常见问题及解答.ppt

慢性乙诗型病毒性肝炎治疗中的常见问题及解答

* * * * * * This table summarises the safety and tolerability profiles of available agents. In general IFNs are poorly tolerated, being associated with flu-like side-effects and emotional lability. In addition, additional safety monitoring is required for patients taking IFNs. In general, most antiviral agents are very well tolerated and require no additional monitoring. Adefovir shares this good tolerability profile but can be associated with nephrotoxicity and therefore requires monitoring of renal function every 12 weeks. * * * * * * 应注意排除由药物、酒精和其他因素所致的ALT升高,也应排除因应用降酶药物后ALT暂时性正常。 * * * *

文档评论(0)

1亿VIP精品文档

相关文档